We came across a bullish thesis on Sarepta Therapeutics, Inc. on 24K Research’s Substack. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc.'s share was trading at $18.88 as of February 20th. SRPT’s trailing and forward P/E were 169.47 and 8.67 respectively according to Yahoo Finance.
[caption id="attachment_1016269" align="aligncenter" width="768"]Sarepta Therapeutics (SRPT) has emerged as a resilient leader in genetic medicine, demonstrating steady performance even as broader...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.